Acne medication Market Research Report Information By Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, and Others), By Formulation (Topical Medications and Oral Medications), By Type (Prescription Medicines and Over-The-Counter Medicines), By Acne Type (Non-Inflammatory Acne and Inflammatory Acne), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, and E-Commerce), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

Global Acne medication Market Overview

Acne medication Market Size was valued at USD 10.5 Billion in 2022. The acne medication market industry is projected to grow from USD 10.8 Billion in 2023 to USD 14.3 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.50% during the forecast period (2023 - 2032). Increased in prevalence of acne diseases and presence of robust acne medications in pipeline are the key market drivers enhancing the market growth.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

October 2023: tbh Skincare partnered with Coles, one of the biggest supermarket retailers in Australia, for the sale of its acne treatment in 857 Coles outlets nationwide.

September 2023: Glenmark Pharmaceuticals Ltd and Cosmo Pharmaceuticals NV entered into a distribution and licensing agreement for the acne treatment ointment Winlevi for Europe and South Africa.

December 2022: Beiersdorf AG made public the purchase of a Belgian company, S-Biomedic NV for further enhancement of its capabilities in the industry.

September 2022: La Roche-Posay started selling online the Effaclar Salicylic Acid Acne Treatment Serum, specially formulated to care for adult acne.

Acne medication Market Trends

Integration of technology in treatment solutions is driving the market growth

Advancements in dermatological technology are shaping trends in the acne medication market. Tele-dermatology and mobile applications are being increasingly utilized for remote consultations, monitoring, and personalized treatment plans. Technologies like artificial intelligence (AI) are aiding in the development of innovative skincare solutions by analyzing individual skin conditions and recommending tailored acne treatments. This integration of technology not only enhances accessibility to dermatological expertise but also promotes patient adherence to prescribed regimens, contributing to more effective acne management. This factor drives the Market CAGR.

Additionally, Consumers are showing a growing preference for natural and clean label ingredients in acne medications. With an increasing awareness of the potential side effects associated with certain synthetic compounds, there's a shift towards plant-based, organic, and cruelty-free formulations. Herbal extracts, essential oils, and botanical ingredients known for their anti-inflammatory and antibacterial properties are gaining popularity. Skincare brands are responding to this trend by launching product lines that emphasize transparency in ingredients, catering to the demand for effective yet gentle solutions that align with broader wellness and sustainability trends.

The acne medication market is witnessing a move towards personalized skincare solutions. Brands are leveraging technology and data analytics to offer personalized treatment plans based on individual skin types, lifestyles, and specific acne concerns. Customization extends beyond the choice of ingredients to include the format of products, such as cleansers, serums, or spot treatments, allowing users to build tailored skincare routines. This trend aligns with the broader shift in the beauty and skincare industry towards recognizing and celebrating the uniqueness of each individual's skin, fostering a more inclusive approach to acne management. For instance, In January 2022, Galderma S.A. concluded its purchase of ALASTIN Skincare, Inc. after receiving an antitrust clearance from federal authorities of the U.S. Rising consumer interest and increasing popularity of aesthetic skin care procedures had led to advancement in demand for valuable products. Thus, driving the acne medication market revenue.

Acne medication Market Segment Insights

Acne medication Therapeutic Class Insights

The acne medication market segmentation, based on Therapeutic Class includes Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, and Others. The dominating therapeutic class is Retinoids. Retinoids, including compounds like tretinoin and adapalene, hold a prominent position in acne treatment due to their effectiveness in promoting skin cell turnover, preventing the formation of new comedones, and reducing inflammation. Simultaneously, the fastest-growing therapeutic class is Salicylic Acid. Salicylic Acid has witnessed rapid growth in demand owing to its efficacy in treating acne by exfoliating the skin, unclogging pores, and reducing inflammation.

Acne medication Formulation Insights

The acne medication market segmentation, based on Formulation, includes Topical Medications and Oral Medications. The dominating formulation is Topical Medications. Topical medications, including creams, gels, and lotions, play a pivotal role in acne treatment by directly targeting affected skin areas. Simultaneously, the fastest-growing formulation is Oral Medications. Oral medications, such as antibiotics and hormonal therapies, are experiencing rapid growth due to their effectiveness in treating severe and persistent cases of acne.

Acne medication Type Insights

The acne medication market segmentation, based on Type, includes Prescription Medicines and Over-The-Counter Medicines. The dominating type is Prescription Medicines. Prescription medications, which include retinoids, antibiotics, and hormonal treatments, are critical in addressing moderate to severe cases of acne. These formulations often require a healthcare professional's prescription due to their potency and potential side effects. Conversely, the fastest-growing type is Over-The-Counter (OTC) Medicines. OTC acne medications, such as those containing salicylic acid and benzoyl peroxide, are witnessing rapid growth driven by increased consumer awareness, accessibility, and preference for self-care.

Acne medication Acne Type Insights

The acne medication market segmentation, based on Acne Type, includes Non-Inflammatory Acne and Inflammatory Acne. Inflammatory Acne stands as the dominating category. This is due to the prevalence of red, swollen, and painful breakouts requiring targeted and potent treatments. Conversely, the fastest-growing category is Non-Inflammatory Acne, encompassing milder forms like blackheads and whiteheads. The rapid growth in this category is attributed to an increasing emphasis on preventive skincare routines and heightened awareness, as consumers actively seek products for early-stage acne management.

Acne medication Acne Distribution Channel Insights

The acne medication market segmentation, based on Distribution Channel, includes Retail Stores, Pharmacies & Drug Stores, and E-Commerce. Retail Stores serve as the dominating distribution channel. This dominance is driven by the widespread availability of acne treatments in physical retail outlets, ranging from supermarkets to specialized beauty stores. Simultaneously, E-Commerce emerges as the fastest-growing distribution channel. The surge in online purchasing can be attributed to the convenience and extensive product information available on e-commerce platforms.

Figure1: Acne medication Market, by Distribution channel, 2022&2032(USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Acne medication Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American acne medication market area will dominate this market, owing to high prevalence of acne-related skin conditions will boost market growth in this region.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure2: ACNE MEDICATION MARKET SHARE BY REGION 2022 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe acne medication market accounts for the second-largest market share due to the increasing emphasis on skincare and dermatological health, with consumers seeking advanced and clinically proven acne medications. Further, the German acne medication market held the largest market share, and the UK acne medication market was the fastest growing market in the European region

The Asia-Pacific Acne medication Market is expected to grow at the fastest CAGR from 2023 to 2032. This is due to the rising prevalence of acne-related skin conditions. Moreover, China’s acne medication market held the largest market share, and the Indian acne medication market was the fastest growing market in the Asia-Pacific region.

Acne medication Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the acne medication market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, acne medicationindustry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the acne medication industry to benefit clients and increase the market sector. In recent years, the acne medication industry has offered some of the most significant advantages. Major players in the acne medication market, including GLAXOSMITHKLINE PLC (GSK), JOHNSON & JOHNSON, MYLAN N.V., BAUSCH HEALTH COMPANIES INC., PFIZER INC., and others, are attempting to increase market demand by investing in research and development operations.

Beiersdorf AG is a German multinational company that operates in the field of skincare and cosmetics. Founded in 1882, the company has its headquarters in Hamburg, Germany. Beiersdorf is known for its extensive range of skincare and beauty products, including popular brands such as Nivea, Eucerin, and La Prairie. Nivea, one of Beiersdorf's flagship brands, is recognized ly for its diverse skincare offerings, ranging from moisturizers and creams to sunscreens and deodorants. Eucerin focuses on dermatological skincare products, addressing various skin concerns with clinically-tested formulations. La Prairie, positioned as a luxury skincare brand, offers premium anti-aging and skincare solutions. December 2022 - Beiersdorf AG announced the acquisition of a Belgium company, S-Biomedic NV, to strengthen its expertise in the market.

Galderma is a multinational pharmaceutical company specializing in dermatology. Founded in 1981, the company is headquartered in Lausanne, Switzerland. Galderma is a joint venture between Nestlé and L'Oréal, making it a leader in the dermatology and skincare market. The company focuses on the research, development, and marketing of dermatological solutions, offering a wide range of products for skin health. Galderma's portfolio includes prescription drugs, over-the-counter skincare products, and aesthetic solutions. The company is known for brands such as Cetaphil, Epiduo, and Restylane. March 2022 - Galderma introduced its breakthrough skincare cream, Twyneo to treat moderate to severe facial acne, to the U.S. market at the American Academy of Dermatology (AAD) Annual Meeting.

Key Companies in the acne medication market include.

• GLAXOSMITHKLINE PLC (GSK)


• JOHNSON & JOHNSON


• MYLAN N.V.


• BAUSCH HEALTH COMPANIES INC.


• PFIZER INC.


• TEVA PHARMACEUTICAL INDUSTRIES LTD


• SUN PHARMACEUTICAL INDUSTRIES LIMITED


• ALMIRALL SA


• GALDERMA S.A.


• MAYNE PHARMA GROUP LIMITED


• Brunswick Corporation

Acne medication Industry Developments

In April 2024, Allergan Aesthetics introduced a new Acne Clarifying Treatment and Purifying Gel Cleanser under the brand SkinMedica.

In June 2023, Cutera was granted FDA acceptance for AviClear as an acne treatment in the USA.

In March 2022, GALDERMA launched TWYNEO cream for the treatment of moderate to severe acne, containing a blend of 0.1% tretinoin and 3% benzoyl peroxide.

In the launch of Nutrafol Skin in direct-to-consumer hair healthcare, the brand aims at completely acne-prone skin with a formulated daily supplement support in February 2024.

Sun Pharma Canada Inc. put PRABSORICA LD on the shelves in Canada in December 2023. ABSORICA is a new postimsotretinoin LD formulation designed to treat resistant nodular and/or inflammatory acne conglobata and strenuous acne in patients who are 12 years or older.

Acne medication Market Segmentation

Acne medication Therapeutic Class Outlook

• Retinoid


• Antibiotic


• Salicylic Acid


• Benzoyl Peroxide


• Other

Acne medication Formulation Outlook

• Topical Medication


• Oral Medication

Acne medication Type Outlook

• Prescription Medicine


• Over-the-counter medicines

Acne medication Acne Type Outlook

• Non-inflammatory acne


• Inflammatory acne

Acne medication Distribution Channel Outlook

• Retail Store


• Pharmacy & Drug Store


• E-Commerce

Acne medication Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America
  
  
  
  

Report Attribute/Metric	Details
Market Size2022	USD 10.5 Billion
Market Size 2023	USD 10.8 Billion
Market Size2032	USD 14.3 Billion
Compound Annual Growth Rate (CAGR)	3.50% (2023-2032)
Base Year	2022
Market Forecast Period	2023-2032
Historical Data	2018- 2022
Market Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered	Therapeutic Class, Formulation, Type, Acne Type, Distribution Channel and Region
Geographies Covered	North America, Europe, AsiaPacific, and the Rest of the World
Countries Covered	The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled	GLAXOSMITHKLINE PLC (GSK), JOHNSON & JOHNSON, MYLAN N.V., BAUSCH HEALTH COMPANIES INC., PFIZER INC
Key Market Opportunities	·         Increased Increase in prevalence of acne diseases
Key Market Dynamics	·         Presence of robust acne medications in pipeline